Catalyst Wire Dossier Catalyst Wire Dossier

flecainide acetate inhalation solution

flecainide acetate · InCarda Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for flecainide acetate inhalation solution, covering 2023-10-30 to 2023-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation [Phase 3]

See pricing